Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
548
-
Total shares
-
214M
-
Shares change
-
+11.5M
-
Total reported value, excl. options
-
$25.9B
-
Value change
-
+$1.39B
-
Put/Call ratio
-
0.7
-
Number of buys
-
288
-
Number of sells
-
-254
-
Price
-
$121.24
Significant Holders of ALEXION PHARMACEUTICALS INC - COM (ALXN) as of Q1 2017
578 filings reported holding ALXN - ALEXION PHARMACEUTICALS INC - COM as of Q1 2017.
ALEXION PHARMACEUTICALS INC - COM (ALXN) has 548 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 214M shares
.
Largest 10 shareholders include FMR LLC (27M shares), PRICE T ROWE ASSOCIATES INC /MD/ (19.3M shares), BlackRock Inc. (18.6M shares), VANGUARD GROUP INC (14.5M shares), STATE STREET CORP (11.3M shares), JENNISON ASSOCIATES LLC (9.63M shares), BAKER BROS. ADVISORS LP (6.54M shares), AMERIPRISE FINANCIAL INC (6.15M shares), SANDS CAPITAL MANAGEMENT, LLC (5.24M shares), and ORBIMED ADVISORS LLC (3.71M shares).
This table shows the top 548 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.